Japan’s Otsuka to buy drug maker Avanir for $3.5 billion
December 02, 2014 at 07:12 AM EST
Otsuka is buying the California-based Avanir for $17 a share in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.